Name | Cancer type | #Gene | Platform | #Patients | Pathological settings |
---|---|---|---|---|---|
Lin07 | colorectal cancer | 4428 | Affymetrix Human Genome U133A Array | 55 | 29 non-recurrence vs. 26 recurrence |
Barrier06 | colorectal cancer | 4428 | Affymetrix Human Genome U133A Array | 50 | 25 non-recurrence vs. 25 recurrence |
Wang05 | breast cancer | 4428 | Affymetrix Human Genome U133A Array | 286 | 180 non-metastasis vs. 106 metastasis |
Van02 | breast cancer | 4203 | Agilent oligonucleotide Hu25K microarray | 295 | 217 non-metastasis vs. 78 metastasis |
Jones05 | clear-cell renal cell carcinoma | 4428 | Affymetrix Human Genome U133A Array | 55 | 23 normal vs. 32 ccRCC |
Wuttig09 | clear-cell renal cell carcinoma | 4428 | Affymetrix Human Genome U133 Plus 2.0 Array | 68 | 29 good prognosis vs. 39 poor prognosis |
Sanchez10 | non-small cell lung cancer | 4428 | Affymetrix Human Genome U133 Plus 2.0 Array | 91 | 45 normal vs. 46 tumor |
Beer02 | non-small cell lung cancer | 2644 | Affymetrix Human Full Length HuGeneFL Array | 86 | 24 dead vs. 62 alive |
Riker08 | melanoma | 4428 | Affymetrix Human Genome U133 Plus 2.0 Array | 82 | 42 non-metastatic vs. 40 metastatic |
Freije04 | gliomas | 4428 | Affymetrix Human Genome U133A Array | 85 | 59 dead vs. 26 alive |